Global Nuclear Medicine Diagnostics Market 2017 Demand, Insights, Key Players, Segmentation and Forecast to 2022

Published On: Aug 2017

Format: PDF

Publisher: QY Research

Pages: 129

Report ID: 105251

Notes:
Sales, means the sales volume of Nuclear Medicine Diagnostics
Revenue, means the sales value of Nuclear Medicine Diagnostics

This report studies sales (consumption) of Nuclear Medicine Diagnostics in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Agfa-Gevaert
Cardiarc
Digirad Corporation
Gamma Medica
GE Healthcare
Hologic
BC Technical
CMR Naviscan
Positron Corporation
Segami Corporation
Philips Healthcare
Siemens

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Nuclear Medicine Diagnostics in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Nuclear Medicine Diagnostics in each application, can be divided into
Application 1
Application 2

Table of Contents

Global Nuclear Medicine Diagnostics Sales Market Report 2017
1 Nuclear Medicine Diagnostics Overview
1.1 Product Overview and Scope of Nuclear Medicine Diagnostics
1.2 Classification of Nuclear Medicine Diagnostics
1.2.1 Type I
1.2.2 Type II
1.3 Application of Nuclear Medicine Diagnostics
1.3.1 Application 1
1.3.2 Application 2
1.4 Nuclear Medicine Diagnostics Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Nuclear Medicine Diagnostics (2012-2022)
1.5.1 Global Nuclear Medicine Diagnostics Sales and Growth Rate (2012-2022)
1.5.2 Global Nuclear Medicine Diagnostics Revenue and Growth Rate (2012-2022)

2 Global Nuclear Medicine Diagnostics Competition by Manufacturers, Type and Application
2.1 Global Nuclear Medicine Diagnostics Market Competition by Manufacturers
2.1.1 Global Nuclear Medicine Diagnostics Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Nuclear Medicine Diagnostics Revenue and Share by Manufacturers (2012-2017)
2.2 Global Nuclear Medicine Diagnostics (Volume and Value) by Type
2.2.1 Global Nuclear Medicine Diagnostics Sales and Market Share by Type (2012-2017)
2.2.2 Global Nuclear Medicine Diagnostics Revenue and Market Share by Type (2012-2017)
2.3 Global Nuclear Medicine Diagnostics (Volume and Value) by Regions
2.3.1 Global Nuclear Medicine Diagnostics Sales and Market Share by Regions (2012-2017)
2.3.2 Global Nuclear Medicine Diagnostics Revenue and Market Share by Regions (2012-2017)
2.4 Global Nuclear Medicine Diagnostics (Volume) by Application

3 United States Nuclear Medicine Diagnostics (Volume, Value and Sales Price)
3.1 United States Nuclear Medicine Diagnostics Sales and Value (2012-2017)
3.1.1 United States Nuclear Medicine Diagnostics Sales and Growth Rate (2012-2017)
3.1.2 United States Nuclear Medicine Diagnostics Revenue and Growth Rate (2012-2017)
3.1.3 United States Nuclear Medicine Diagnostics Sales Price Trend (2012-2017)
3.2 United States Nuclear Medicine Diagnostics Sales and Market Share by Manufacturers
3.3 United States Nuclear Medicine Diagnostics Sales and Market Share by Type
3.4 United States Nuclear Medicine Diagnostics Sales and Market Share by Application

4 China Nuclear Medicine Diagnostics (Volume, Value and Sales Price)
4.1 China Nuclear Medicine Diagnostics Sales and Value (2012-2017)
4.1.1 China Nuclear Medicine Diagnostics Sales and Growth Rate (2012-2017)
4.1.2 China Nuclear Medicine Diagnostics Revenue and Growth Rate (2012-2017)
4.1.3 China Nuclear Medicine Diagnostics Sales Price Trend (2012-2017)
4.2 China Nuclear Medicine Diagnostics Sales and Market Share by Manufacturers
4.3 China Nuclear Medicine Diagnostics Sales and Market Share by Type
4.4 China Nuclear Medicine Diagnostics Sales and Market Share by Application

5 Europe Nuclear Medicine Diagnostics (Volume, Value and Sales Price)
5.1 Europe Nuclear Medicine Diagnostics Sales and Value (2012-2017)
5.1.1 Europe Nuclear Medicine Diagnostics Sales and Growth Rate (2012-2017)
5.1.2 Europe Nuclear Medicine Diagnostics Revenue and Growth Rate (2012-2017)
5.1.3 Europe Nuclear Medicine Diagnostics Sales Price Trend (2012-2017)
5.2 Europe Nuclear Medicine Diagnostics Sales and Market Share by Manufacturers
5.3 Europe Nuclear Medicine Diagnostics Sales and Market Share by Type
5.4 Europe Nuclear Medicine Diagnostics Sales and Market Share by Application

6 Japan Nuclear Medicine Diagnostics (Volume, Value and Sales Price)
6.1 Japan Nuclear Medicine Diagnostics Sales and Value (2012-2017)
6.1.1 Japan Nuclear Medicine Diagnostics Sales and Growth Rate (2012-2017)
6.1.2 Japan Nuclear Medicine Diagnostics Revenue and Growth Rate (2012-2017)
6.1.3 Japan Nuclear Medicine Diagnostics Sales Price Trend (2012-2017)
6.2 Japan Nuclear Medicine Diagnostics Sales and Market Share by Manufacturers
6.3 Japan Nuclear Medicine Diagnostics Sales and Market Share by Type
6.4 Japan Nuclear Medicine Diagnostics Sales and Market Share by Application
7 Southeast Asia Nuclear Medicine Diagnostics (Volume, Value and Sales Price)
7.1 Southeast Asia Nuclear Medicine Diagnostics Sales and Value (2012-2017)
7.1.1 Southeast Asia Nuclear Medicine Diagnostics Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Nuclear Medicine Diagnostics Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Nuclear Medicine Diagnostics Sales Price Trend (2012-2017)
7.2 Southeast Asia Nuclear Medicine Diagnostics Sales and Market Share by Manufacturers
7.3 Southeast Asia Nuclear Medicine Diagnostics Sales and Market Share by Type
7.4 Southeast Asia Nuclear Medicine Diagnostics Sales and Market Share by Application
8 India Nuclear Medicine Diagnostics (Volume, Value and Sales Price)
8.1 India Nuclear Medicine Diagnostics Sales and Value (2012-2017)
8.1.1 India Nuclear Medicine Diagnostics Sales and Growth Rate (2012-2017)
8.1.2 India Nuclear Medicine Diagnostics Revenue and Growth Rate (2012-2017)
8.1.3 India Nuclear Medicine Diagnostics Sales Price Trend (2012-2017)
8.2 India Nuclear Medicine Diagnostics Sales and Market Share by Manufacturers
8.3 India Nuclear Medicine Diagnostics Sales and Market Share by Type
8.4 India Nuclear Medicine Diagnostics Sales and Market Share by Application

9 Global Nuclear Medicine Diagnostics Manufacturers Analysis
9.1 Agfa-Gevaert
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Agfa-Gevaert Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Cardiarc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Cardiarc Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Digirad Corporation
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Digirad Corporation Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Gamma Medica
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Gamma Medica Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 GE Healthcare
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 GE Healthcare Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Hologic
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Hologic Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 BC Technical
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 BC Technical Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 CMR Naviscan
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 CMR Naviscan Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Positron Corporation
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Positron Corporation Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Segami Corporation
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Nuclear Medicine Diagnostics Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Segami Corporation Nuclear Medicine Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Philips Healthcare
9.12 Siemens

10 Nuclear Medicine Diagnostics Maufacturing Cost Analysis
10.1 Nuclear Medicine Diagnostics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Nuclear Medicine Diagnostics
10.3 Manufacturing Process Analysis of Nuclear Medicine Diagnostics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Nuclear Medicine Diagnostics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Nuclear Medicine Diagnostics Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Nuclear Medicine Diagnostics Market Forecast (2017-2022)
14.1 Global Nuclear Medicine Diagnostics Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Nuclear Medicine Diagnostics Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Nuclear Medicine Diagnostics Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Nuclear Medicine Diagnostics Price and Trend Forecast (2017-2022)
14.2 Global Nuclear Medicine Diagnostics Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Nuclear Medicine Diagnostics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Nuclear Medicine Diagnostics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Nuclear Medicine Diagnostics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Nuclear Medicine Diagnostics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Nuclear Medicine Diagnostics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Nuclear Medicine Diagnostics Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Nuclear Medicine Diagnostics Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Nuclear Medicine Diagnostics Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source